<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01812733</url>
  </required_header>
  <id_info>
    <org_study_id>OXN9513</org_study_id>
    <nct_id>NCT01812733</nct_id>
  </id_info>
  <brief_title>Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives</brief_title>
  <official_title>An Observational Study of Quality of Life, Resource Use and Costs Associated With Treatment of Severe Pain - a Comparison of a Combination of Oxycodone and Naloxone (Targiniq) Versus Oxycodone and Laxatives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mundipharma AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mundipharma AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the non-interventional study is to compare the quality of life, health care&#xD;
      resource use and costs between the use of a combination of oxycodone and naloxone (Targiniq)&#xD;
      versus oxycodone and laxatives for patients with severe pain, and to evaluate the&#xD;
      cost-effectiveness of treatment with Targiniq.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>8 Weeks</time_frame>
    <description>Two visits performed over 8 weeks</description>
  </primary_outcome>
  <enrollment type="Actual">37</enrollment>
  <condition>Pain</condition>
  <condition>Opioid Induced Constipation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The patients have severe pain treated with opioids and will be enrolled at different&#xD;
        clinics in Sweden&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Male or non-pregnant female ≥18 years of age&#xD;
&#xD;
          -  Malignant or non-malignant opioid sensitive pain&#xD;
&#xD;
          -  Must sign an informed consent form (ICF)&#xD;
&#xD;
          -  Must have a stable daily dose of oxycodone prolonged release formulation titrated to&#xD;
             analgesic effect (as to be assessed by clinical experts)&#xD;
&#xD;
          -  Use of laxatives for concomitant opioid-induced constipation in an adequate dose and&#xD;
             length of time and without sufficient effect&#xD;
&#xD;
          -  BFI ≥30 and state a discomfort caused by the constipation at screening&#xD;
&#xD;
          -  Ability to answer the patient questionnaires and have an estimated overall life&#xD;
             expectancy of at least six (6) months&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  History of, or on-going, abuse of alcohol and/or drugs&#xD;
&#xD;
          -  Inability to read and understand written instructions, ICF or questionnaires&#xD;
&#xD;
          -  Constipation not related to opioid use&#xD;
&#xD;
          -  Unsuitable patient for other reason(s) in the opinion of the investigator&#xD;
&#xD;
          -  Inpatients, if admission and/or discharge is expected during study period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rehabiliteringsmedicinska kliniken</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>March 14, 2013</study_first_submitted>
  <study_first_submitted_qc>March 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2013</study_first_posted>
  <last_update_submitted>August 6, 2015</last_update_submitted>
  <last_update_submitted_qc>August 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Opioid-Induced Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

